CFTR gene mutations in adults with disseminated bronchiectasis

Area of Science:

• Genetics
• Pulmonology
• Medical Research

Background:

• Cystic Fibrosis (CF) presents with variable clinical manifestations, including respiratory issues like lung infections, asthma, and COPD.
• Disseminated bronchiectasis (DB) is a significant respiratory syndrome in CF patients.

Purpose of the Study:

• To investigate the role of the cystic fibrosis transmembrane conductance regulator (CFTR) gene in adult chronic pulmonary disease.
• To determine the frequency of CFTR gene mutations in patients with clinically isolated disseminated bronchiectasis.

Main Methods:

• Studied 32 adult patients diagnosed with disseminated bronchiectasis (DB) and isolated respiratory syndrome.
• Performed comprehensive analysis of all CFTR gene exons and flanking regions for mutations.

Main Results:

• Identified a significantly increased frequency of CFTR gene mutations in DB patients.
• Detected thirteen CFTR gene mutations across sixteen alleles, including six known CF mutations and four potentially novel disease-causing mutations (D192N, 406-2 AdeltaC).
• Found three rare substitutions (R31C, L997F, T1220I) possibly linked to mild CFTR-related disease, with several patients exhibiting compound heterozygous or heterozygous mutations.

Conclusions:

• CFTR gene mutations may contribute to the development of bronchiectatic lung disease, potentially within a multifactorial genetic context.
• These findings are crucial for genetic counseling regarding disseminated bronchiectasis and CFTR-related disorders.